Double lung transplantation in an HIV‐positive patient with Mycobacterium kansasii infection

• Published in: Transplant infectious disease 2019-02, Vol.21 (1), p.e12999-n/a
• Main Authors: Ambaraghassi, Georges, Ferraro, Pasquale, Poirier, Charles, Rouleau, Danielle, Fortin, Claude
• Format: Article
• Language: English
• Subjects: Acquired immune deficiency syndrome; AIDS; Bronchiolitis obliterans; Bronchopneumonia; Case reports; Corticoids; Corticosteroids; Graft rejection; Health risks; HIV; Human immunodeficiency virus; Illnesses; Infections; Liver; Liver transplantation; Lung diseases; Lung transplantation; Lungs; Mycobacterium; Patients; Sputum; Transplantation; Transplants & implants
• ISSN: 1398-2273; 1399-3062
• DOI: 10.1111/tid.12999

Good outcomes with kidney and liver transplantation in HIV‐positive patients have led clinicians to recommend lung transplantation in HIV‐positive patients based on extrapolated data. Pre‐transplant mycobacterial infection is associated with an increased risk of developing new infection or aggravating existing infection, though it does not contraindicate transplantation in non‐HIV–infected patients. However, no data exists regarding the outcome of HIV‐positive patients with pre‐transplant mycobacterial infection. We report a case of double lung transplantation in a 50‐year‐old HIV‐positive patient with alpha‐1 antitrypsin deficiency. Prior to transplantation, Mycobacterium kansasii was isolated in one sputum culture and the patient was considered merely colonized as no clinical evidence of pulmonary or disseminated disease was present. The patient successfully underwent a double lung transplantation. Nontuberculous mycobacterial infection was diagnosed histologically on examination of native lungs. Surveillance and watchful waiting were chosen over treatment of the infection. HIV remained under control post‐transplantation with no AIDS‐defining illnesses throughout the follow‐up. A minimal acute rejection that responded to increased corticosteroids was reported. At 12 months post‐transplant, a bronchiolitis obliterans syndrome was diagnosed after a drop in FEV1. No evidence of isolation nor recurrence of nontuberculous mycobacteria was reported post‐transplantation. At 15 months post‐transplant, the patient remained stable with an FEV1 of 30%. The presence of pre‐transplant nontuberculous mycobacterial infection did not translate into recurrence of nontuberculous mycobacterial infection post‐transplant. Whether it contributed to bronchiolitis obliterans syndrome remains unknown.